Deborah M. Heuvelman
Pfizer (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Peroxisome Proliferator-Activated Receptors, Cholesterol and Lipid Metabolism, Nitric Oxide and Endothelin Effects, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.(1989)1,271 cited
- → Human Vascular Permeability Factor(1989)286 cited
- → Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin.(1990)136 cited
- → Synergy between Celecoxib and Radiotherapy Results from Inhibition of Cyclooxygenase-2-Derived Prostaglandin E2, a Survival Factor for Tumor and Associated Vasculature(2004)106 cited
- → Inhibition of Cyclooxygenase-2 by Celecoxib Reverses Tumor-Induced Wasting(2004)87 cited
- → Free Bone Graft Reconstruction of Irradiated Facial Tissue(1991)52 cited
- → Large-Scale Purification of Myeloperoxidase from HL60 Promyelocytic Cells: Characterization and Comparison to Human Neutrophil Myeloperoxidase(2000)38 cited
- → Physical and kinetic characterization of recombinant human cholesteryl ester transfer protein(1996)31 cited
- → Discovery of Chiral N,N-Disubstituted Trifluoro-3-amino-2-propanols as Potent Inhibitors of Cholesteryl Ester Transfer Protein(2000)30 cited
- → Inhibition of cholesteryl ester transfer protein by substituted dithiobisnicotinic acid dimethyl ester: involvement of a critical cysteine(2000)27 cited